Moreover, TGF-β stimulation in MEG-01 cells, which are derived from a CML patient having BCR-ABL fusion protein, and in U937 cells, which are derived from lymphoma, results in suppressed CD48 expression levels and lower susceptibility to NK targeting48. The gene discussed is BCR; the disease is lymphoma.